Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]
ISIS Rating Summary
ISIS Price Target Summary
- Highest: $18.00 (Leerink Swann)
- Lowest: $7.00 (Jefferies)
- Average: $12.50
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$12.50 (-38.9%)
Avg. $ Target:
$12.50 (-38.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/17/2012 | Summer Street | Downgrade | Neutral (Buy) |
N/A (N/A) |
10.27 | 20.46 | 99.22% | Details |
| 9/6/2012 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
14.79 | 20.46 | 38.34% | Details |
| 3/26/2012 | Canaccord Genuity » Updated 8/7/2012 |
New Coverage | Hold (N/A) |
11.00 (9.00) |
8.57 | 20.46 | 138.74% | Details |
| 8/5/2010 | Collins Stewart | Downgrade | Neutral (N/A) |
N/A (N/A) |
9.43 | 20.46 | 116.97% | Details |
